Short answer: Early studies link GLP-1 medications to slightly more cough and throat symptoms, but none has measured silent reflux directly. If your throat changed after you started Ozempic, Wegovy, Mounjaro or Zepbound, it's worth getting checked, and it's worth adjusting how you eat and sleep.
In this post
What is silent reflux (LPR)?
What the early research shows
Throat symptoms to watch for on a GLP-1
What helps
When to see your doctor or an ENT
The takeaway
Many people on a GLP-1 expect heartburn as a possible side effect. Far fewer expect a raspy voice, a cough that won't quit, or the constant urge to clear their throat. Because there's no burning in the chest, they don't connect those symptoms to reflux, and neither does anyone else.
If that sounds like you, this post explains what silent reflux is, what the early research on GLP-1s shows (it's new and limited), and what you can do about it.
What is silent reflux (LPR)?
Silent reflux, or laryngopharyngeal reflux (LPR), is reflux that travels all the way up to your throat and voice box. It's called silent because many people with it have little or no heartburn. Instead, the symptoms show up in the throat: clearing, hoarseness, cough, or a feeling that something is stuck.
The tissue in your throat is much more delicate than the lining of your esophagus, so even small amounts of reflux can irritate it. Silent reflux also often doesn't show up on a scope, which is part of why it gets missed. I explain why in silent reflux symptoms with a normal scope.
What the early research shows
Two large studies published in 2026 looked at GLP-1s and throat symptoms. Both are observational database studies. They looked back at medical records, so they can show links but can't prove cause.
Gallagher, 2026 (chronic cough in type 2 diabetes). This study compared people with type 2 diabetes who were prescribed a GLP-1 with people on other diabetes medications. GLP-1 users had a slightly higher risk of chronic cough (a hazard ratio of 1.12). When GLP-1 users were compared only with people on SGLT2 inhibitors, another type of diabetes medication, the difference was no longer significant (1.03). After the researchers excluded people who already had GERD, the comparison with SGLT2 inhibitors was significant again (1.14).
In plain words: a small signal, which disappeared in one comparison and showed up again in another.
Shah, 2026 (throat symptoms in adults with obesity). This study used the TriNetX database and included 617,296 adults with obesity taking a GLP-1. At 6 months, GLP-1 users had higher odds of any laryngeal (voice box) symptom (an odds ratio of 1.19) and of cough (1.46). Tirzepatide (Mounjaro and Zepbound) was not significantly linked to these symptoms. The groups were matched only on age, sex, race and ethnicity, so other differences between them could explain part of the result, which makes its numbers weaker.
What neither study measured: silent reflux itself. No study has measured LPR in GLP-1 users, with no reflux symptom scores and no pH-impedance testing (the test that measures reflux reaching the throat). These studies tell us GLP-1 use is associated with a little more cough and throat symptoms. They can't tell us whether reflux is the reason.
My read: the link is real enough to take seriously and small enough not to panic about. GLP-1s slow how quickly your stomach empties, and a fuller stomach gives reflux more chances to travel up. That's a plausible path to the throat, and it's one we can work with.
Throat symptoms to watch for on a GLP-1
These are the symptoms that often point to silent reflux:
Throat clearing, often after meals
Hoarseness or a voice that tires easily
Cough, often dry and nagging
A lump-in-the-throat feeling, as if something is stuck when nothing is there
A sore or raw throat without a cold or infection to explain it
Throat reflux doesn't follow the same pattern as heartburn. In one study that measured reflux reaching the throat in 126 people with silent reflux, about 74% of those reflux episodes happened during the day, outside the hour after meals. Only about 5% happened at night, and more than half of the people had no nighttime throat reflux at all. So don't rule out reflux just because your symptoms show up in the middle of the day.
If you notice any of these symptoms, write down when they started, especially relative to starting the medication or a dose increase, and what time of day they're worst. That pattern is useful information for your doctor and for anyone helping you with your plan.
For ways to calm these symptoms day to day, read my 8 tips to get rid of acid reflux throat symptoms.
What helps
Start with the eating principles in my GLP-1 and acid reflux guide: smaller meals, protein first, moderate fat, and a last meal well before bed. Because most throat reflux happens while you're upright during the day, smaller meals matter all day long, not just at dinner. Then add these.
Give dinner time to move. On a GLP-1, dinner can still be in your stomach at bedtime. An earlier, smaller dinner means less is there to reflux once you lie down.
Left-Side Sleeping. Your stomach sits to the left of your esophagus. When you sleep on your left side, the spot where your esophagus joins your stomach sits above the pool of stomach contents, so reflux would have to travel uphill. On your right side, that junction can sit below the stomach contents, which makes reflux easier. This matters most if your symptoms show up at night or when you first wake up.
Alginate Therapy. Alginates are raft-forming products taken after meals and at bedtime. They form a gel-like layer that floats on top of your stomach contents and creates a physical barrier at the top of the stomach. This is part of my approach with clients who have throat symptoms. No study has tested it in people taking GLP-1s, so think of it as a practical option rather than a proven one, and check with your doctor or pharmacist about timing with your other medications.
Understand pepsin. Pepsin, a digestive enzyme that travels up with reflux, is a big part of why throat symptoms linger. I explain how it works in why PPIs often don't work for LPR and why you're always clearing your throat. If you've seen alkaline water recommended for this, I break down the evidence in alkaline water for pepsin and silent reflux.
When to see your doctor or an ENT
Throat symptoms can come from many causes besides reflux, so some need to be checked. See your doctor or an ear, nose and throat specialist (ENT) if you have:
Hoarseness lasting more than 3 weeks
Trouble swallowing
Coughing up blood
Unexplained weight loss beyond what's expected on your medication
Changes in your breathing
If your throat changed after starting a GLP-1, tell your prescriber, too. Please don't stop or change your medication on your own. That decision belongs to you and your prescriber together.
The takeaway
Early studies link GLP-1s to slightly more cough and throat symptoms, and no study has measured silent reflux directly. If your throat changed after you started, take it seriously: get the red flags checked, keep meals smaller through the day, give dinner time to move, sleep on your left side, and ask about alginates as an after-meal and bedtime option.
Throat symptoms are the reflux symptoms people wait longest to address. If your throat changed after starting a GLP-1, our team of reflux dietitians can help you sort out what's driving it. Apply to work 1:1 at https://www.mollypelletier.com/acid-reflux-specialist.
With love,
Molly Pelletier, MS, RD
Verified Citations
Gallagher TJ, Razura DE, Li A, Kim I, Vukkadala N, Barbu AM. Glucagon-Like Peptide-1 Receptor Agonists and Chronic Cough. JAMA Otolaryngol Head Neck Surg. 2026;152(2):163-171. Retrospective propensity-matched cohort, adults with type 2 diabetes. Chronic cough, GLP-1 vs other second-line diabetes drugs aHR 1.12 (1.08 to 1.16); vs SGLT2 inhibitors 1.03 (0.98 to 1.09); excluding prior GERD, vs SGLT2 inhibitors 1.14 (1.02 to 1.28). PMID 41296333. https://doi.org/10.1001/jamaoto.2025.4181
Shah P, Kayekjian D, Nguyen SA, Meenan K, O'Rourke AK. Association of Glucagon-Like Peptide-1 Receptor Analogues and Laryngeal Symptoms in Obese Adults. Laryngoscope. 2026. Retrospective TriNetX cohort, 617,296 adults with obesity on GLP-1s vs controls, matched on age, sex, race and ethnicity. 6-month any laryngeal symptom OR 1.19 (1.16 to 1.21); cough OR 1.46; tirzepatide not significant. PMID 42584027. https://doi.org/10.1002/lary.70808
Lechien JR, Bobin F, Dapri G, et al. Hypopharyngeal-Esophageal Impedance-pH Monitoring Profiles of Laryngopharyngeal Reflux Patients. Laryngoscope. 2021;131(2):268-276 (epub 2020). Prospective, 126 LPR patients: 73.99% of hypopharyngeal reflux episodes outside the 1-hour post-meal window, 20.49% within 1 hour after meals, 5.52% at night; 58.73% had no nighttime episodes. PMID 32438465. https://doi.org/10.1002/lary.28736
